White label – Pompe disease - ClinicalTrials.eu

Study on Dasatinib and Quercetin for Patients with Osteoporosis or Osteopenia

Not recruiting

2 1 1 1
Investigated Diseases:
- Osteopenia
- Osteoporosis
Investigated Drugs:
- Dasatinib
Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Venetoclax
- Azacitidine
Study of MK-1088 and Pembrolizumab for Patients with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Mk-1088
- Pembrolizumab
Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Not recruiting

3 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Efanesoctocog Alfa
+8
Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing Multiple Sclerosis Starting Anti-CD20 Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Ocrelizumab
- Rituximab
Study on Colchicine for Patients with Acute Heart Failure

Not recruiting

3 1 1 1
Investigated Diseases:
- Cardiac failure acute
Investigated Drugs:
- Colchicine
Study on the Safety and Immune Response of GSK’s Herpes Zoster Vaccine in Immunocompromised Children Aged 1-17 with Kidney Transplants

Not recruiting

2 1 1
Investigated Drugs:
- Gskvx000000014593
Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Acute Leukemia

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Venetoclax
+1
Study on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases

Not recruiting

2 1 1 1
Investigated Diseases:
- Interstitial lung disease
Investigated Drugs:
- Xenon (129Xe)
- Gadobutrol
Study on Montelukast for COVID-19 Patients at Higher Risk in Primary Care

Not recruiting

3 1 1 1
Investigated Drugs:
- Montelukast

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies